Robert Considine

Background

About Robert Considine

Dr. Robert V. Considine joined the Division of Endocrinology at Indiana University School of Medicine (IUSM) as an Assistant Professor in 1997, and was promoted to Professor in 2013. Prior to his appointment at IUSM, he was on the faculty of the Department of Medicine at Thomas Jefferson University in Philadelphia, where he had completed his doctoral training. Dr. Considine’s research is focused on understanding the contribution of obesity to the development of diabetes and its complications. In early work he made seminal observations about the function of the adipose tissue hormone leptin in humans. More recently the Considine lab has focused on effects of bariatric surgery to alter gut hormone release and improve glucose homeostasis and insulin sensitivity. In collaboration with David Kareken, PhD at IUSM, Dr. Considine is also utilizing neuroimaging techniques to understand the reward system response to food cues in human subjects. Dr. Considine is currently the Associate Director of the IUSM NIH funded Diabetes Center and oversees the Analyte Laboratory, which provides quantitation of adipokines, cytokines, gut peptides and hormones from human and animal samples. He is also the Statewide Director for Endocrine and Reproductive Biology, a second year course in the medical school curriculum. Dr. Considine began as Director of the Diabetes Center at the Indiana Biosciences Research Institute (IBRI) in August 2018. IBRI is an independent institute for applied scientific research enabling industry and academic research partners to collaborate on projects and sponsor research to improve human health and nutrition. The Diabetes Center is focused on understanding the molecular basis of diabetes and its complications, with the goal to develop novel interventions.